Rik Vandevenne United States

River Cities Capital Fund is a private equity firm founded in 1994 and based in Cincinnati, Ohio. The firm manages approximately $500 million under management and is currently investing out of its 2014 vintage $200 fund. The firm looks to make investments of $5-$15 million initially up to $20 million over the investments lifetime. The firm is willing to invest throughout the United States and is looking to make approximately 4-6 equity investments over the next 6 to 9 months.

River Cities Capital Funds
Director 

Peter Varney

Covance

Dr Claus Vielsack Germany

For more than 35 years STRATEC Biomedical AG is a business partner for the development and manufacture of fully automated analyzer systems. It's headquarter is located in Birkenfeld, Germany and it has nearly 500 employees in 5 locations worldwide. The public owned company has cooperations with 15 of the 20 IVD companies worldwide and has boosted its annual sales from USD 10.4 million in 1998 (IPO) to USD 122.4 million in 2014. STRATEC has strived to achieve market-leading expertise and to build a technology pool that is unique to its industry. The company invests in a variety of fields within the diagnostic and life science sector including medical devices.

Website:
www.stratec.com
Year Founded
1979
Medtech Subsector
Dr Claus Vielsack
STRATEC Biomedical AG
Member Board of Management Product Development 

Pushpa Vijayaraghavan

Sathguru Management Consultants is a niche emerging markets focused strategy and innovation advisory firm.  Founded in 1985 in India, Sathguru’s expertise includes South Asia focused corporate strategy, M&A and innovation advisory encompassing international innovation access, advancement and commercialization.  Sathguru has a team of around 150 professionals across service offerings and has offices in India and USA. 

Service Provider Type
Sathguru, Inc.
BIO

Pushpa is a Vice President at Sathguru Inc., Sathguru's operations in Boston, MA. She primarily focuses on life sciences and advises enterprises, academia, and venture capitalists on advancing innovation and leveraging opportunities in India and other countries in South Asia. Pushpa's prior experience includes leading advisory assignments in PwC and E&Y and short stints with the Export Import Bank of India and University of Michigan Technology Transfer Office. She has a BA from Osmania University, an MBA from the University of Michigan, and is a member of the Institute of Chartered Accountants of India.

Eron Villarreal United States

Yuzu Labs, based in Silicon Valley, is a research startup that aims to make clinical, behavioral, and social research more accessible, easier, faster, and cheaper. We've recently launched a private beta of our initial product named StudyPages. Researchers can use this web application to quickly set up a dedicated webpage for their studies, share with target communities, and track signups. Please visit the site to learn more: https://studypages.com
Year Founded
2014
Service Provider Type
Eron Villarreal
Yuzu Labs
LinkedIn logo Co-Founder 
BIO

Eron holds a computer science engineering degree and has broad experience in Silicon Valley startups spanning search (Inflection), mobile advertising (InMobi), electronic medical records (drchrono), and medical device development (Scanadu). At Yuzu Labs, Eron manages all things tech with a passion for quality, teamwork, and technology driven problem solving. After college, he lived in Japan for 5+ years, where he built a new life from scratch and became a hybrid of American and Japanese values.

I crave hard problems, believe that people united by a goal can change the world, work tirelessly for something I believe in, and am an optimist with no fear, despite the odds, as everything works out in the end.

Phillip Vincent United States

Plug and Play Ventures (a successor fund to Amidzad Partners) is a private/family investment vehicle based in Silicon Valley, CA. The fund is a structured organization for making angel investments in pre-seed or seed rounds. Investments are in the form of equity; in the next 6 months Plug and Play Ventures expects to make about 5-10 seed investments of $50,000-100,000 and an additional 40 pre-seed investments of $25,000, and is hoping to increase their allocations in the healthcare sector. Plug and Play also provides a three-month accelerator program. The firm will consider investing in companies worldwide.

Plug and Play Ventures is interested in investing in medical technology, and invests in subsectors in which the firm can apply expertise; typically this means products that have a significant software component. Healthcare IT, biosensors, wearables and health monitoring devices are of interest. While the firm is open to investing in any indication, Plug and Play is particularly interested in diabetes & blood glucose monitoring, personal fitness, and mental/behavioral disorders. In the healthcare IT sector, Plug and Play Ventures is interested in both consumer applications and enterprise software, but is not interested in diagnostic software such as genomic, proteomic, or molecular diagnostic algorithms; however, optimization and data analysis software for hospitals and diagnostic laboratories is of interest.

Plug and Play Tech Center
Corporate Partnerships Manager 

Shafique Virani Switzerland

F. Hoffmann-La Roche Ltd. is a Swiss global health-care company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Roche is looking for first-in-class or best-in-class opportunities that address diseases of unmet medical need and have the potential to revolutionize the standard of care. Roche focuses on their main disease therapy areas – oncology and Immuno-oncology, ophthalmology, infectious diseases and neurosciences–as well as looking at opportunities in promising technologies and early-stage collaborations. Beyond the asset, Roche always look for the right partnership and cultural fit. Roche also seeks collaboration in diagnostics, specifically biomarkers.

Roche / Genentech
Global Head Partnering (Neuro) 

Sharon Vosmek

Astia is an organization whose mission is to provide women-led startups access to capital resources and executive leadership. Astia was founded in 2013 and is based in San Francisco California with additional offices in New York New York and London United Kingdom. Astia typically provides access to capital to women-led life science companies through two programs: Astia Venture Lunches and Astia Angels and is in the process of developing a third program: Astia Fund. Companies that apply to Astia Venture Lunches will be vetted by Astia?s Expert Sift process. The selected companies are invited to present to a room of accredited investors: VCs and angels. Companies applying to Astia are also considered by Astia Angels and the investments from Astia Angels are typically under $1 million. Astia is stage agnostic though companies applying should be able to show traction and proof of concept. Companies can be global and must have at least one woman in a leadership position of significant influence and holding equity.
Astia Angels
CEO 

Carla Vozone

Website:
www.hovione.com
Hovione
Sr. Director Product Development and Licensing 

Dr Garrett Vygantas United States

Jump Capital was founded in 2012 and is based in Chicago, with an additional office in San Francisco. The firm is investing from a $250m fund, and is interested in a variety of sectors including the life science field. For life science investments, Jump Capital typically allocates $2-15 million, and prefers to invest in Series B-C rounds. Jump Capital invests in the USA and Canada, and has previously invested in 6 healthcare companies.

Jump Capital invests in medical devices, diagnostics, digital and mobile health, and healthcare services. The firm is open to opportunities in any clinical indication. Jump Capital is only interested in devices and diagnostics that have in-human data.

Jump Capital
LinkedIn logo Partner